Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Wingstop (WING)
16K → 14K shares (−8%)
Intuitive Surgical (ISRG)
6,608 → 6,272 shares (−5%)
Becton Dickinson (BDX)
17K → 16K shares (−5%)
Silvaco Group (SVCO)
176K → 173K shares (−2%)
Paylocity (PCTY)
25K → 23K shares (−8%)
nVent Electric (NVT)
35K → 14K shares (−61%)
Resources Connection (RGP)
559K → 548K shares (−2%)
Exagen (XGN)
494K → 485K shares (−2%)
Sound Financial Bancorp (SFBC)
52K → 52K shares (−1%)
Titan International (TWI)
293K → 287K shares (−2%)
Vertex (VERX)
206K → 189K shares (−8%)
Trisalus Life Sciences (TLSI)
485K → 476K shares (−2%)
James River Group Holdings (JRVR)
502K → 492K shares (−2%)
Mirion Technologies, Inc. (MIR)
124K → 114K shares (−8%)
Bristol Myers Squibb (BMY)
36K → 34K shares (−5%)
Postal Realty Trust (PSTL)
81K → 79K shares (−2%)
Atmus Filtration Technologies Inc. (ATMU)
275K → 38K shares (−86%)
Scholar Rock Holding (SRRK)
37K → 34K shares (−8%)
Freshworks (FRSH)
202K → 186K shares (−8%)
Stryker Corporation (SYK)
6,007 → 5,911 shares (−2%)
Arbutus Biopharma (ABUS)
393K → 385K shares (−2%)
Medtronic (MDT)
25K → 23K shares (−5%)
ESCO Technologies Inc. (ESE)
7,374 → 4,700 shares (−36%)
Cigna (CI)
6,073 → 5,761 shares (−5%)
Pagaya Technologies (PGY)
88K → 86K shares (−2%)